Evrysdi approved by European Commission as first and only at home treatment for spinal muscular atrophy – Roche
Roche announced that the European Commission (EC) has approved Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients two months of age and older,… read more.